Beyond the Prescription Pad: Over-the-Counter Oral Contraceptive Gains FDA Approval - Frankly Speaking Ep 342

<p>Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: <a href='https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342'>https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-342</a></p> <p>Overview: In July of 2023, the FDA made a monumental decision to approve Opill, marking the first time an oral contraceptive will be made available without a prescription. The inaugural over-the-counter oral contraceptive is a progesterone-only pill. Join us to discuss the underlying rationales driving this decision and the prospective implications it might have on medical practice as well as women’s health.</p> <p>Episode resource links:</p> <ul><li> <p>Biggs, AM, Ralph, L, Morris, N, Ehrenreich, K, Perritt, J, Kapp, N, Blanchard, K, White, K,  Barar, Grossman, RD. A cross-sectional survey of U.S. abortion patients’ interest in obtaining medication abortion over the counter, Contraception, Volume 109, 2022, Pages 25-31, ISSN 0010-7824, <a href='https://doi.org/10.1016/j.contraception.2022.01.010.'>https://doi.org/10.1016/j.contraception.2022.01.010.</a></p> <p> </p> <p> </p> </li> <li> <p>Chen, Q.J. Xiang, W.P. Zhang, D.K., Wang, R.P. Luo, Y.F. Kang, J.Z. Cheng, L.N. Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial, Human Reproduction, Volume 26, Issue 9, September 2011, Pages 2316–2321, <a href='https://doi.org/10.1093/humrep/der181'>https://doi.org/10.1093/humrep/der181</a></p> <p> </p> </li> <li> <p>Raine, TR; Ricciotti, N; Sokoloff, A; Brown, B; Hummel, A; Harper, C. An Over-the-Counter Simulation Study of a Single-Tablet Emergency Contraceptive in Young Females. Obstetrics &amp; Gynecology 119(4):p 772-779, April 2012. | DOI: 10.1097/AOG.0b013e31824c0aed</p> <p> </p> </li> <li> <p><a href='https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive'>https://www.fda.gov/news-events/press-announcements/fda-approves-f